Clinical trial
A Prospective, Open-label Trial of Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children
NCT01217099 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Open-label Trial of Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children
- Lead sponsor
- Chongqing Medical University
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 31, 2007
- Completion date
- May 31, 2010
- Enrollment
- 47 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
refractory mycoplasma pneumoniae pneumonia